Skip to content
Search

Latest Stories

NICE seeks feedback on annual BMI checks for adults with long-term conditions

Regular monitoring of BMI and waist-to-height ratio is a "powerful tool" to help prevent type 2 diabetes and heart disease.

NICE calls for annual BMI checks for adults with long-term conditions

Annual BMI measurements create early intervention opportunities for weight management

Getty Images

The National Institute for Health and Care Excellence (NICE) has published a draft quality standard recommending annual Body mass index (BMI) and waist-to-height measurements for adults with long-term conditions to help prevent weight-related complications.

A consultation has been launched to gather feedback from healthcare professionals and commissioners on the feasibility of implementing these proposals within the NHS.


The draft quality standard calls for yearly BMI measurements for all patients with long-term conditions and additional waist-to-height measurements for those with a BMI below 35.

NICE stated that these annual measurements will help identify individuals at risk of weight-related complications earlier, enabling them to receive timely support to prevent future health issues.

Professor Jonathan Benger, deputy chief executive and chief medical officer at NICE, explained: “These simple annual measurements create opportunities for early intervention and conversations about long-term health and wellbeing.”

“By identifying trends before they become problems, clinical practitioners can help people prevent more serious health complications down the line.”

He emphasised that tracking BMI and waist-to-height ratio annually is “a powerful tool” in preventing conditions such as type 2 diabetes, heart disease, and other obesity-related health issues.

Currently, while people with long-term conditions undergo routine physical health checks, BMI and waist-to-height measurements are not consistently recorded.

NICE’s new approach aims to address this inequality in care.

Its draft quality standard focuses on adults with conditions such as COPD, diabetes, heart failure, learning disabilities, rheumatoid arthritis, schizophrenia, and stroke, though this isn't a definitive list.

“We want to hear from healthcare professionals and commissioners during the consultation period to understand whether the proposals we've made can be implemented in the NHS,” said Dr Rebecca Payne, GP and chair of quality standards advisory committee at NICE.

NICE’s draft quality standard also stresses the importance of improving access to weight management services for people with learning disabilities, providing information on available interventions, and ensuring follow-up care for those prescribed weight management medicines or discharged from bariatric surgery services.

The consultation, which opened on 18 March, will run until 15 April 2025, with the final quality standard expected in August 2025.

More For You

Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less